Search Results 781-790 of 16229 for monoclonal antibody

  1. Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease - Mayo Clinic

    Abnormal specific antibody response to immunization; ... Has received any lymphocyte depleting agents including anti-CD20 monoclonal antibodies, alemtuzumab, ATG ...

  2. Publications - Pedro Horna, M.D. - Mayo Clinic

    Single Antibody Detection of T-Cell Receptor alphabeta Clonality by Flow ... monoclonal and polyclonal antibodies. Am J Clin Pathol. 2011 Dec; 136 (6): ...

  3. Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2 - Mayo Clinic

    infusion reaction or hypersensitivity (CTCAE Grade 3 or higher) with monoclonal antibody treatment - Clinically significant cardiac disease, including but ...

  4. Safety & Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization - Mayo Clinic

    About this study. The purpose of this trial is to determine the safety and efficacy of eculizumab in the prevention of antibody mediated rejection (AMR) in ...

  5. Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer - Mayo Clinic

    0) hypersensitivity reactions to monoclonal antibodies, or history of anaphylaxis. Vaccination within 28 days of the first dose of study drugs and while on ...

  6. A Study to Evaluate VSV-hIFNbeta-NIS to Treat Patients with Relapsed/Refractory Multiple Myleoma, Acute Myeloid Leukemia, or T-cell Lymphoma - Mayo Clinic

    - Immunotherapy (monoclonal antibodies) =< 4 weeks prior to registration - ... antibody response, and increased numbers of tumor reactive T-cells. VSV-IFNβ ...

  7. Multiple myeloma - Diagnosis and treatment - Mayo Clinic

    Other medical conditions you have, especially any plasma conditions, such as monoclonal gammopathy of undetermined significance, also called MGUS. All your ...

  8. Cancer Immunology and Immunotherapeutics Research Program - Mayo Clinic Research

    ... antibody-targeted chemotherapeutics. Research aims. The Grohne Cancer ... Aim 2: The purpose of this aim is to develop innovative immune interventions using ...

  9. Stopping Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients - Mayo Clinic

    Other Monoclonal Antibodies: Subjects who have received any monoclonal antibody (other than XOLAIR®) to treat inflammatory disease within 5 half-lives of Visit ...

  10. Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) - Mayo Clinic

    ... monoclonal antibody * For Cohorts G, H, and I: Has symptomatic ascites or pleural effusion * For Cohort I: Has clinically active diverticulitis, intra ...